New cisplatin schedule in combination with aclarubicin (ACR) with high response rate in recurrent gynecological adenocarcinomas

This publication has 22 references indexed in Scilit:

• Continuous cisplatin (24-hour) and 5-fluorouracil (120-hour) infusion in recurrent head and neck squamous cell carcinoma
  Cancer, 1988
• Chemotherapy for advanced or recurrent gynecologic cancer
  Cancer, 1987
• Continuous Cisplatin Infusion in Combination with Vincristine and High-Dose Methotrexate for Advanced Osteogenic Sarcoma
  American Journal of Clinical Oncology, 1987
• A phase I trial of continuous infusion cisplatin
  Cancer, 1987
• A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study
  Cancer, 1986
• Phase II trial of cisplatin as second-line chemotherapy in patients with advanced or recurrent endometrial carcinoma A Gynecologic Oncology Group study
  American Journal of Clinical Oncology, 1984
• Cis-diamminedichloroplatinum (II) by 5-day continuous infusion a new dose schedule with minimal toxicity
  Cancer, 1984
• Continuous Intravenous Infusion Combination Chemotherapy for Head and Neck Squamous Cell Carcinoma
  Oncology, 1984
• 24-Hour infusion of cis-platinum in head and neck cancers
  Cancer, 1978
• Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry
  Biochemical Medicine, 1977